Design and characterization of a device to quantify the magnetic drug targeting efficiency of magnetic nanoparticles in a tube flow phantom by magnetic particle spectroscopy

The aim of magnetic drug targeting (MDT) is to transfer a therapeutic drug coupled to magnetic nanoparticles (MNP) to desired disease locations (e.g. tumor region) with the help of magnetic field gradients. To transfer the MDT approach into clinical practice a number of important issues remain to be solved. We developed and characterized an in-vitro flow phantom to provide a defined and reproducible MDT environment. The tube system of the flow phantom is directed through the detection coil of a magnetic particle spectroscopy (MPS) device to determine the targeting efficiency. MPS offers an excellent temporal resolution of seconds and an outstanding specific sensitivity of some nanograms of iron. In the flow phantom different MNP types, magnet geometries and tube materials can be employed to vary physical parameters like diameter, flow rate, magnetic targeting gradient, and MNP properties.